A purported charity called The Breast Cancer Survivors Foundation existed for six years, raising money through direct mailers and soliciting donors over the phone. It took in about $3 million per year, spinning heartwarming tales in its mailings of helping patients. This turned out to not actually be true, and those millions went to the professional fundraiser who ran the …
NYS Entity Status
NYS Filing Date
MARCH 01, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN NOT-FOR-PROFIT CORPORATION
2013 - EUEL A. CORBIN BRAIN CANCER FOUNDATION
AROUND THE WEB
- Fake Breast Cancer Charity Must Shut Down, Pay $350K To Real Charities
By Laura Northrup - Friday Jun 16, 2017
- In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions
By Alex Lash - Wednesday May 31, 2017
Has the era of genetic oncology arrived? Last week, the biomedical world took a notable step in that direction when the FDA said Merck’s drug pembrolizumab (Keytruda), already one of the world’s most successful cancer immunotherapies, could now treat any tumor with a particular genetic fingerprint. It was the first time a drug has been […]
- Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests?
By Ben Fidler - Saturday Jun 3, 2017
When the FDA last week approved Merck’s cancer drug pembrolizuamb (Keytruda) for tumors with a specific genetic signature, regardless of what body part they originated in, it was a watershed moment for oncology and a victory for the concept of precision medicine. But Merck isn’t alone; others are following suit with similar plans, and their […]
- 31 August, 2016 – Episode 582 – This Week in Science Podcast (TWIS)
By Kirsten Sanford - Friday Sep 2, 2016
Interview w/ Carl Zimmer, A Signal, Solar System Bodies, Monkey Guts, Blood-Thirsty Brains, Tasmanian Evolution, Whisker Feels, counting Cuttlefish, Oldest European, Oldest Tree, Toxo V. Cancer, And Much More...
- The Mind-Boggling Math That (Maybe) Mapped the Brain in 11 Dimensions
By Megan Molteni - Tuesday Jun 13, 2017
Henry Markram is back with a new publication on his controversial Blue Brain project. The math behind it may be more important than the results.
- New DNA Test Detects Mutations in Urine of Bladder Cancer Patients Over a Decade Before Diagnosis
Tuesday May 30, 2017
For diagnosis 1 year after sample collection, the test detected mutations in 90% of patients.
- Scientist's 'Tenacious' Research Paved Way for Breast-Cancer Treatment
Friday Jun 16, 2017
When Angela Hartley Brodie first came up with a new way to treat breast cancer in the 1970s, there was little interest from the pharmaceutical sector. But her persistence over the years paid off.
- Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs
By Frank Vinluan - Wednesday Jun 14, 2017
The IPO window is still open for clinical-stage drug companies, and Athenex is now the latest one to pass through it. The cancer drug developer raised $66 million through a public stock offering on Wednesday, funding that the company will devote mostly to a pair of cancer drugs in late-stage clinical development. Athenex priced its […]